August 10th 2008 | Biologics | 0 Comments
The U.S. Food and Drug Administration (FDA), which is reviewing whether to approve the experimental biologic ustekinumab for the treatment of moderate to severe plaque psoriasis, will take an additional three months before it renders its decision. This means we can expect a decision by the FDA near the end of 2008.
At a June
READ THE FULL POST
August 7th 2008 | Health care system, Impact of psoriasis, Insurance, Public policy issues, Treatment | 0 Comments
The Washington Post reported on August 4 that health and life insurance companies can cheaply and quickly get access to electronic prescription records of insurance applicants. At a cost of about $15 per request, private companies, including Milliman IntelliScript and Ingenix, will compile an insurance applicant’s prescription history from databases of past insurance claims. Both
READ THE FULL POST
August 6th 2008 | Uncategorized | 0 Comments
The U.S. Senate’s powerful Appropriations Committee recently included Report language urging the National Institutes of Health (NIH) to increase funding for and attention to psoriasis research. While it does not have the force of law, this language is closely watched by NIH and other key decision-makers as they allocate a whopping $30 billion annually in
READ THE FULL POST
August 6th 2008 | Uncategorized | 0 Comments
Parathyroid Hormone (1-34) [PTH (1-34)], a topical cream that showed promise as a new treatment for psoriasis, failed to significantly reduce psoriasis symptoms in a Phase II clinical study, the company reported on July 31, 2008.
Manhattan Pharmaceuticals, the company sponsoring the study, compared two dosages of PTH (1-34) to placebo in more
READ THE FULL POST
August 4th 2008 | Uncategorized | 0 Comments
The videos are all in, and now the judging begins. An impressive collection of 80 videos has been created for the 2008 Psoriasis Cure Now Video Contest. Unfortunately, only 10 will win prizes.
On August 11th, we’ll announce the 10 Finalists. Then we’ll need your input on which two should win the $5,000
READ THE FULL POST
